⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRKR News
Marker Therapeutics, Inc. Common Stock
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
globenewswire.com
MRKR
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
globenewswire.com
MRKR
Form 8-K
sec.gov
MRKR
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
globenewswire.com
MRKR
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
MRKR
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
globenewswire.com
MRKR
Remix Therapeutics Appoints Mythili Koneru, MD, PhD, as Chief Medical Officer
globenewswire.com
REMX
MRKR
LLY
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
globenewswire.com
MRKR
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
MRKR
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
globenewswire.com
MRKR